Kymera Therapeutics Inc.

NASDAQ: KYMR · Real-Time Price · USD
46.85
-0.11 (-0.23%)
At close: Jun 16, 2025, 3:59 PM
46.70
-0.32%
Pre-market: Jun 17, 2025, 04:50 AM EDT

Kymera Therapeutics Revenue

Kymera Therapeutics reported an annual revenue of $47.07M, reflecting a -40.11% growth. For the quarter ending March 31, 2025, Kymera Therapeutics generated $22.1M in revenue.
Revenue (ttm)
$47.07M
Revenue Growth
-40.11%
Price / Sales Ratio
64.14
Revenue / Employee
$226.31K
Employees
208
Market Cap
3.05B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.